BioWorld MedTech

May 21, 2012

EuroPCR 2012: Robust new generation valves fix leaks and flaws

PARIS The wide adoption of transcatheter aortic valve implantation (TAVI) techniques is funding an impressive industrial effort to fix the flaws in first generation devices. Read More

MedTech Investing Conference: 'Elsewhere' seen as alternative locales for financings, trials

Digestive Diseases Week 2012: Med-tech gets to the gut of the matter at DDW

Washington roundup: Report on NIH funding hints at panic over OUS research

Deals roundup: Agilent acquires Dako from EQT for $2.2 billion

People in the News

Financings roundup: SQI closes C$2.3M through second tranche of placement

MDD's Fun Facts

EuroPCR notebook: Boston Scientific reveals 2-year results for PLATINUM study

Agreements/contracts: Sequenom, Coventry Health update participation network

Product Briefs

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

BioWorld

Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

BioWorld

Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...

Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

BioWorld Science

Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.